Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

Lucid Diagnostics Inc

LUCD
0,9534
-0,0566 (-5,60%)
16 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/11/202414:01PRNUSPAVmed Provides Business Update and Third Quarter 2024..
13/11/202414:15EDGAR2Form 8-K - Current report
13/11/202414:01PRNUSLucid Diagnostics Provides Business Update and Third Quarter..
12/11/202422:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202413:00EDGAR2Form 8-K - Current report
07/11/202414:01PRNUSLucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter..
05/11/202414:01PRNUSLucid Diagnostics Expands Direct Contracting Initiative with..
31/10/202413:31PRNUSPAVmed to Hold a Business Update Conference Call and Webcast..
30/10/202413:31PRNUSLucid Diagnostics to Hold a Business Update Conference Call..
15/10/202413:51PRNUSLucid Diagnostics Receives Notice of Allowance for Key..
09/10/202414:01PRNUSLucid Diagnostics to Participate in the 2024 Maxim..
08/10/202413:49PRNUSLucid Diagnostics to Join Global Medtech Leaders at The..
01/10/202414:01PRNUSLucid Diagnostics Holds Inaugural #CheckYourFoodTube..
24/9/202414:01PRNUSAmerican Foregut Society's 2024 Annual Meeting to Highlight..
16/9/202422:30PRNUSPAVmed Announces Efforts to Regain Compliance with Nasdaq..
10/9/202413:56PRNUSLucid Diagnostics to Host Symposium on Non-Endoscopic..
03/9/202413:51PRNUSLucid Diagnostics Signs Memorandum of Understanding with..
20/8/202414:16PRNUSLucid Diagnostics Announces Publication of Analytical..
13/8/202414:16PRNUSThe American Foregut Society Formally Requests Medical..
13/8/202414:01PRNUSPAVmed Provides Business Update and Second Quarter 2024..
12/8/202414:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202414:15EDGAR2Form 8-K - Current report
12/8/202414:07PRNUSLucid Diagnostics Provides Business Update and Second..
08/8/202414:31PRNUSLucid Diagnostics Holds First Major Directly-Contracted..
06/8/202414:15PRNUSLucid Diagnostics Announces Positive Data from ENVET-BE..
05/8/202414:15PRNUSLucid Diagnostics to Participate in Upcoming Investor..
30/7/202414:15PRNUSPAVmed to Hold a Business Update Conference Call and Webcast..
29/7/202414:15PRNUSLucid Diagnostics to Hold a Business Update Conference Call..
23/7/202414:01PRNUSLucid Diagnostics Announces Record Quarterly EsoGuard® Test..
19/7/202415:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
19/7/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
12/7/202422:30EDGAR2Form S-3/A - Registration statement under Securities Act of..
11/7/202414:31PRNUSLucid Diagnostics Launches New Corporate Website
02/7/202413:55PRNUSLucid Diagnostics Announces Positive Data from its ESOGUARD..
12/6/202414:05PRNUS4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuard®..
06/6/202415:48EDGAR2Form DEF 14A - Other definitive proxy statements
06/6/202414:40EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
24/5/202423:26EDGAR2Form PRE 14A - Other preliminary proxy statements
24/5/202422:32EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
24/5/202422:30EDGAR2Form 8-K - Current report
14/5/202412:05EDGAR2Form 8-K - Current report
14/5/202402:43PRNUSPAVmed Provides Business Update and First Quarter 2024..
13/5/202414:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202414:00PRNUSLucid Diagnostics Provides Business Update and First Quarter..
10/5/202403:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202413:49PRNUSLegacy Sponge-on-a-String Esophageal Cell Collection Device..
08/5/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202413:50EDGAR2Form 8-K - Current report
07/5/202413:39PRNUSLucid Diagnostics Closes Series B / B-1 Preferred Stock..
Apertura: 1,03 Min: 0,9684 Max: 1,035
Chiusura: 1,01

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network